Article Text

Download PDFPDF
Transporter associated protein expression in uveal melanoma
  1. S Krishnakumar1,
  2. S A Lakshmi1,
  3. D Abhyankar2,
  4. J Biswas1
  1. 1Department of Ocular Pathology, Vision Research Foundation, Sankara Nethralaya, Chennai, India
  2. 2Evanston North Western Health Care, Evanston, IL, USA
  1. Correspondence to: Dr S Krishnakumar Vision Research Foundation, Sankara Nethralaya, 18 College Road, Chennai-600 006, Tamil Nadu, India; drkrishnakumar_2000yahoo.com

Abstract

Background/aim: Transporter associated protein (TAP) is important for presenting peptides to major histocompatibility complex (MHC) class I molecules. Defects in TAP lead to decreased MHC class I expression. The immunoexpression of human leucocyte antigen (HLA) class I molecules and the TAP1 subunit were studied in primary uveal melanomas and correlated with the cell types and extrascleral extension.

Methods: The HLA class I antigen and TAP1 subunit were analysed by immunoperoxidase staining with monoclonal antibodies on 45 primary uveal melanoma archival specimens. The tumours were divided into two groups—group A: tumours with no extrascleral extension; group B tumours with extrascleral extension/liver metastasis. Immunoanalysis was done by a semiquantitative method.

Results: HLA class I antigen and TAP1 were decreased in 35 of 35 tumours with no extrascleral extension and positive in six of 10 tumours with liver metastasis. Decreased immunoexpression of HLA class I antigen and TAP1 in uveal melanomas with no extrascleral extension was significant (p<0.001). HLA class I antigen and TAP1 were negative in spindle cell melanomas (p<0.001).

Conclusions: HLA class I antigen and TAP1 expression were decreased in uveal melanomas with no extrascleral extension and in spindle cell melanomas. Decreased expression of TAP1 may lead to decreased expression of HLA class I antigen in uveal melanomas. This preliminary observation deserves further investigation, which may shed more light on the immune escape mechanisms of this tumour and thus enable novel therapeutic strategies.

  • HLA, human leucocyte antigen
  • MHC, major histocompatibility complex
  • TAP, transporter associated protein
  • cell types
  • extrascleral extension
  • immunohistochemistry
  • transporter associated protein
  • uveal melanoma
  • HLA, human leucocyte antigen
  • MHC, major histocompatibility complex
  • TAP, transporter associated protein
  • cell types
  • extrascleral extension
  • immunohistochemistry
  • transporter associated protein
  • uveal melanoma

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Footnotes

  • Commercial relationships: Nil.